生展生物科技股份有限公司
生展生物科技股份有限公司與其子公司在台灣及中國從事微生物藥用原料、生物農藥、肥料、生化營養品及預防醫學產品之研發、製造與銷售。提供膳食補充劑、保健食品委託製造（含袋裝、液體、錠劑、軟糖等劑型）及自有品牌生化原料。亦提供有機食品 OEM/ODM 及品牌代理服務。公司成立於 1988 年，總部位於台灣台南市。
該股 RSI(6) 為 50.0，處於中性區間，短線無明顯超買超賣訊號。股價站上20日均線，跌破5日、60日、120日均線。KD 指標中性（K=61.8）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | -1 | 0 | 0 | -1 |
| 08-07 | +1 | 0 | +2 | +1 |
| 08-06 | -1 | 0 | 0 | -1 |
| 08-03 | +11 | 0 | 0 | +11 |
| 07-31 | +1 | 0 | 0 | +1 |
| 07-30 | +3 | 0 | 0 | +3 |
| 07-29 | -2 | 0 | 0 | -2 |
| 07-28 | +3 | 0 | 0 | +3 |
| 07-27 | 0 | 0 | 0 | 0 |
| 07-23 | 0 | 0 | 0 | 0 |
| 07-22 | -2 | 0 | 0 | -2 |
| 07-21 | -2 | 0 | 0 | -2 |
| 07-20 | +1 | 0 | 0 | +1 |
| 07-17 | +1 | 0 | 0 | +1 |
| 07-15 | +6 | 0 | 0 | +6 |
| 07-14 | -5 | 0 | 0 | -5 |
| 07-13 | 0 | 0 | 0 | 0 |
| 07-09 | -4 | 0 | +6 | -4 |
| 07-08 | -4 | 0 | 0 | -4 |
| 07-07 | +3 | 0 | 0 | +3 |
| 07-06 | +1 | 0 | 0 | +1 |
| 07-03 | +5 | 0 | 0 | +5 |
| 07-02 | +2 | 0 | 0 | +2 |
| 07-01 | +3 | 0 | 0 | +3 |
| 06-30 | -1 | 0 | 0 | -1 |
| 06-29 | -1 | 0 | 0 | -1 |
| 06-26 | -3 | 0 | 0 | -3 |
| 06-25 | +1 | 0 | 0 | +1 |
| 06-24 | -2 | 0 | 0 | -2 |
| 06-23 | 0 | 0 | 0 | 0 |
| 06-22 | +1 | 0 | 0 | +1 |
| 06-18 | -1 | 0 | 0 | -1 |
| 06-16 | -13 | 0 | 0 | -13 |
| 06-15 | -3 | 0 | 0 | -3 |
| 06-11 | -3 | 0 | 0 | -3 |
| 06-10 | -1 | 0 | 0 | -1 |
| 06-09 | 0 | 0 | 0 | 0 |
| 06-08 | 0 | 0 | 0 | 0 |
| 06-04 | 0 | 0 | 0 | 0 |
| 06-03 | +4 | 0 | 0 | +4 |
| 06-02 | -5 | 0 | 0 | -5 |
| 06-01 | 0 | 0 | 0 | 0 |
| 05-29 | +1 | 0 | 0 | 0 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 2.34 億 | +57.2% | -0.8% |
| 2026/03 | 1.49 億 | +8.0% | -24.2% |
| 2026/02 | 1.38 億 | +6.7% | -17.7% |
| 2026/01 | 1.29 億 | -22.8% | +6.6% |
| 2025/12 | 1.68 億 | +19.8% | +8.3% |
| 2025/11 | 1.40 億 | -18.7% | -17.7% |
| 2025/10 | 1.72 億 | -21.2% | +14.8% |
| 2025/09 | 2.19 億 | +23.0% | +17.5% |
| 2025/08 | 1.78 億 | +6.4% | -9.4% |
| 2025/07 | 1.67 億 | +0.2% | -3.8% |
| 2025/06 | 1.67 億 | -18.6% | +7.8% |
| 2025/05 | 2.05 億 | - | +14.6% |